Search

everythinglearnresearchcommunity

for

Search:↓

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Stretching skin increases a certain protein that attracts stem cells, helping skin regeneration.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

The drug combination was safe and showed promise in treating advanced tumors.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Melanocyte stem cells in hair follicles are key for hair color and could help treat greying and pigment disorders.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Ephrin-A3 helps increase and speed up hair growth in baby mice.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Ephrins slow down skin and hair follicle cell growth.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Hair follicles in people with alopecia have lower levels of a key blood vessel growth protein.

Targeting colon cancer stem cells might lead to better treatment results.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

Some common medications can harm male fertility, but many effects can be reversed.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

ILK and ELMO2 help cells move and stick together, important for wound healing and hair growth.

Gambogic Amide helps maintain hair color and promotes hair growth.